Vitamin D, xanthohumol may offer new approach to obesity epidemic

Two natural compounds, vitamin D and xanthohumol, appear to have the ability to address imbalances in gut microbiota that may set the stage for obesity and metabolic syndrome. 

System may offer new hope for personalized treatment of eczema

Personalized moisturizers based on an individual's own lipid profile may dramatically change the treatment of eczema around the world.

Hospice patients, practitioners face quandary about antibiotic use

A survey suggests there remain many questions about how or whether to use antibiotics with hospice patients, and how such medications are used in end of life care.

Pactamycin analogs offer new, gentler approach to cancer treatment

Compounds being studied at OSU could be part of a new approach to cancer, in which cancer cells and tumors are not so much killed as put to sleep.

No lotions needed: Many animal species produce their own sunscreen

Some animals apparently have the ability to make their own sunscreen, and with further research it's at least possible that a compound may some day help humans do that as well.

Drug prices to treat multiple sclerosis soar, point to larger problem

The soaring price of drugs used to treat multiple sclerosis may be just one sign of a much larger problem in the pharmaceutical industry, a new study concludes.

Survey shows half of older adults in U.S. now taking aspirin

A majority of older Americans are now taking a daily dose of aspirin, even though its use is not recommended by the FDA for many of them.

Publication bias and 'spin' raise questions about drugs for anxiety disorders

Antidepressant drugs used to treat anxiety disorders may not work as well as published studies would have you believe, raising questions about the process used to inform doctors.